Skip to main content
    Z

    Zenas BioPharma, Inc. Common Stock (ZBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $27.75
    -0.18 (-0.64%)

    Market Cap: $1.89B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Zenas BioPharma, Inc. Common Stock (ZBIO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Zenas BioPharma, Inc. Common Stock (ZBIO) has a latest price of $27.75 on Nov 17, 2026, 37.8% below its 52-week high of $44.60. Its price fell 20.7% over the past 12 months.

    Price Chart

    From Sep 2024 to Oct 2026, its highest month-end close was $38.83 in Nov 2025 and its lowest $7.01 in Feb 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart ZBIO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ZBIO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 11.2%, and over 6 months it rose 55.5%.

    PeriodChange
    1 month+3.9%
    3 months-11.2%
    6 months+55.5%
    12 months-20.7%
    12 months, with dividends-20.7%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$28.39-21.8%
    2025$36.31+343.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.2% below its 50-day average of $28.38 and 9.1% above its 200-day average of $25.44.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$27.75
    52-week high$44.60-37.8%
    52-week low$13.50+105.6%
    50-day average$28.38-2.2%
    200-day average$25.44+9.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 75.0%.

    MeasureValue
    1-year beta0.72
    Largest fall, 1 year-64.8%
    Largest fall, 3 years-75.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About ZBIO

    What is ZBIO's 1-year price change?

    Zenas BioPharma, Inc. Common Stock's price fell 20.7% over the past 12 months. With dividends included, the 12-month total return was -20.7%.

    What is ZBIO's 52-week high and low?

    Zenas BioPharma, Inc. Common Stock's 52-week high is $44.60 and its 52-week low is $13.50. Its latest price of $27.75 on Nov 17, 2026 is 37.8% below the high.

    What is ZBIO's beta?

    Zenas BioPharma, Inc. Common Stock's 1-year beta against the S&P 500 is 0.72, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 64.8%.

    Is the ZBIO chart free?

    Yes. Advanced Charting for ZBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.